Breast Cancer | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 1: Breast Cancer

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in breast cancer. Featuring perspectives from Drs Ann Partridge and Mark Pegram, including the following topics: Introduction Case: A woman in her late 40s with ER/PR-negative, HER2-positive metastatic breast cancer (mBC) — Syed F Zafar, MD Clinical Implications of the DESTINY-Breast03 Trial — Elizabeth Guancial, MD Case: A woman in her mid-70s with ER-positive, PR-negative, HER2-positive mBC with bone and brain metastases — Sunil Gandhi, MD DESTINY-Breast03 Trial Chalk Talk — Dr Pegram Postneoadjuvant/Adjuvant Neratinib for HER2-Positive Breast Cancer Chalk Talk — Dr Partridge Case: A woman in her early 50s with ER/PR-positive, HER2-negative mBC — Susmitha Apuri, MD Case: A premenopausal woman in her early 50s with ER/PR-positive, node-positive x 1 breast cancer — Raji Shameem, MD Case: A woman in her early 60s with ER/PR-positive breast cancer — Dr Apuri Genomic Assays in ER-Positive Breast Cancer Chalk Talk — Dr Pegram Selecting a First-Line CDK4/6 Inhibitor for ER-Positive Metastatic Breast Cancer Chalk Talk — Dr Partridge Case: A woman in her early 60s with asynchronous second primary triple-negative breast cancer (TNBC) — Mamta Choksi, MD KEYNOTE-522 Trial Chalk Talk — Dr Pegram OlympiA Trial Chalk Talk — Dr Partridge CME information and select publications